About Aptus Endosystems
Aptus Endosystems is a company based in Sunnyvale (United States) founded in 2002 was acquired by Medtronic in June 2015. Aptus Endosystems has raised $70 million across 3 funding rounds from investors including Medtronic, Synergy Life Science Partner and VCDE Venture Partners. The company has 63 employees. Aptus Endosystems operates in a competitive market with competitors including Endologix, Endoron Medical, Trivascular, Altura Medical and Remon Medical, among others.
- Headquarter Sunnyvale, United States
- Employees 63
- SectorsHealthcare
- Website aptusendo.com
- Social X Facebook
- Acquired by Medtronic (Jun 2015)
- Legal Name Aptus Endosystems, Inc.
Funding Insights of Aptus Endosystems
Aptus Endosystems has successfully raised a total of $70M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in June 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $70M
- Total Rounds 3
- Last Round Series B — $25M
- First Round $30M
(Jan 2009)
- Investors Count 6
All 3 funding rounds of Aptus Endosystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2012 | $25M | Series B | – | Synergy Life Science Partner | |
| Aug 2010 | $15M | Series A | – | Longitude Capital, USVP | – |
| Jan 2009 | $30M | Series A | – | Heron Capital |
7 investors in total: 7 institutional.
Investors in Aptus Endosystems
Aptus Endosystems has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Synergy Life Science Partner and VCDE Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | synergylsp.com | - | |
Tech focused growth stage VC firm investing in North America, Europe & Asia | – | venturecapital.de | Frankfurt Am Main, Germany | |
Private equity firm focused on life science sector | – | longitudecapital.com | Menlo Park, United States | |
VC firm that focuses on early stage investments in the US | – | usvp.com | Menlo Park, United States | |
Growth stage VC fund investing in the US, Europe and Canada | – | oakwoodmedical.com | St. Louis, United States | |
Heron Capital is engaged in private equity investment management. | – | heroncap.com | Indianapolis, United States | |
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States |
Investor details for Aptus Endosystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Aptus Endosystems
4 dated milestones of Aptus Endosystems across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Aptus Endosystems is founded.
- Funding First funding round of $30.0M.
- Funding Latest funding round, Series B, of $25.0M.
- Exit Acquired by Medtronic.
Competitors of Aptus Endosystems
Aptus Endosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endologix, Endoron Medical, Trivascular, Altura Medical and Remon Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endologix.com | 1992 | Irvine, United States | – | 488 | Minimally invasive treatments for aortic disorders are developed and manufactured. | |
| endoronmedical.com | 2019 | Kfar Saba, Israel | $15M | – | Endovascular fixation devices for cardiovascular stent grafts are manufactured. | |
| trivascular.com | 1998 | Santa Rosa, United States | $260.95M | 307 | Designs and manufactures for endovascular aortic repair equipment | |
| alturamedical.com | 2008 | Menlo Park, United States | $49.5M | – | Endovascular devices for aortic aneurysms are developed. | |
| remonmedical.com | 1997 | Caesarea, Israel | $26M | – | Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics. | |
| endovastec.com | 2012 | Shanghai, China | – | – | Medical devices for treating aortic diseases are developed. | |
| nellix.com | 1994 | Palo Alto, United States | $18.2M | – | Medical device catering less invasive treatment of Abdominal Aortic Aneurysms | |
| emblok.com | 2013 | Kalamazoo, United States | $19.75M | – | Embolic protection devices are developed for TAVR procedures. | |
| jotec.com | 2000 | Hechingen, Germany | – | 451 | Stents and Grafts for Aortic and Peripheral arterial disease |
Detailed competitors of Aptus Endosystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Aptus Endosystems
10 companies that operate in the same segment as Aptus Endosystems (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aptus Endosystems
Aptus Endosystems was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Aptus Endosystems is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Aptus Endosystems is a funded company, having raised a total of $70M across 3 funding rounds to date. The company's 1st funding round was a Series A of $30M, raised on Jan 2009.
Aptus Endosystems has 63 employees.
Aptus Endosystems was established in 2002 in Sunnyvale, United States, as a medical device company. Attention is directed toward technologies for endovascular aortic aneurysm repair. Two systems have been created: the Heli-FX EndoAnchor System and the Heli-FX Thoracic EndoAnchor System. FDA 510(k) clearance and CE marking have been obtained for both, with availability in the United States and European Union.
Aptus Endosystems's top competitors include Endologix, Trivascular and Shanghai MicroPort Endovascular MedTech.
Aptus Endosystems has 7 investors. Key investors include Medtronic, Synergy Life Science Partner, VCDE Venture Partners, Longitude Capital, and USVP.
Aptus Endosystems operates through Aptus Endosystems, Inc..
Yes. Aptus Endosystems was acquired by Medtronic in June 2015.